Single award · contract
BPS - Advance the Development of V920, a Vaccine Against Ebola Virus Using a Recombinant Vesicular Stomatitis…
Award ID: HHSO100201600031C
A single federal award, with both ends of the trail linked.
$65.1M
Total award value
Award HHSO100201600031C is a contract from the Department of Health and Human Services to Merck Sharp & Dohme LLC, $65.1M obligated, FY2016 to FY2024, for BPS - Advance the Development of V920, a Vaccine Against Ebola Virus Using a Recombinant Vesicular…. The work is performed in Iowa. It is classified as PSC AN13 (Health R&D Services; Health Care Services; Experimental Development) and NAICS 541711 (Research and Development in Biotechnology). Source
Description
BPS - Advance the Development of V920, a Vaccine Against Ebola Virus Using a Recombinant Vesicular Stomatitis Virus Vector. Igf::ot::igf
Award details
Award typeContract
PIIDHHSO100201600031C
Action date2016
Period97 mo
Awarding agencyDepartment of Health and Human Services →
RecipientMerck Sharp & Dohme LLC →
Place of performanceIowa →
CategoryPSC AN13NAICS 541711
Competed?Not recordedSource
Total (exact)$65,103,309
More awards to Merck Sharp & Dohme LLC
awarded 2021$2.2B
awarded 2014$1.5B
awarded 2017$1.5B
awarded 2013$1.4B
awarded 2012$1.4B
More from Department of Health and Human Services
awarded 2025$110.4B
awarded 2024$100.1B
awarded 2023$92B
awarded 2022$80.5B
awarded 2021$80.5B
Why the labels? The graph is only worth anything if the links are trusted. Facts taken straight from a federal filing are Source; figures we calculate are Computed; links we infer (corporate parents, districts, similar contractors, connections between records) are Inferred, worded carefully, never asserted as fact and never a claim that one thing caused another. Spot an error? Tell us.